|
SET expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.578800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.697600E-01 |
| Normal-vs-Stage2 |
8.172300E-02 |
| Normal-vs-Stage3 |
1.578250E-01 |
| Normal-vs-Stage4 |
3.672200E-01 |
| Stage1-vs-Stage2 |
1.036640E-01 |
| Stage1-vs-Stage3 |
2.494600E-01 |
| Stage1-vs-Stage4 |
5.350400E-01 |
| Stage2-vs-Stage3 |
4.856000E-01 |
| Stage2-vs-Stage4 |
4.515600E-01 |
| Stage3-vs-Stage4 |
8.300000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.731000E-01 |
| Normal-vs-AfricanAmerican |
9.321000E-01 |
| Normal-vs-Asian |
4.832400E-01 |
| Caucasian-vs-AfricanAmerican |
5.504000E-01 |
| Caucasian-vs-Asian |
9.644200E-01 |
| AfricanAmerican-vs-Asian |
5.707000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.230600E-01 |
| Normal-vs-Female |
2.825800E-01 |
| Male-vs-Female |
9.204200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.967400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.034570E-01 |
| Normal-vs-Age(61-80Yrs) |
1.430230E-01 |
| Normal-vs-Age(81-100Yrs) |
1.117640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.608400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.239830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.912560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.838400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.266600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.218200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.964600E-01 |
| Classical-VS-Follicular |
2.943200E-03 |
| Classical-VS-Other |
5.323200E-01 |
| Classical-VS-Normal |
9.168200E-01 |
| Tall-VS-Follicular |
6.884300E-02 |
| Tall-VS-Other |
5.743600E-01 |
| Tall-VS-Normal |
9.652800E-01 |
| Follicular-VS-Other |
6.599400E-01 |
| Follicular-VS-Normal |
1.144060E-02 |
| Other-VS-Normal |
4.768400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.597700E-02 |
| Normal-vs-N1 |
3.262300E-02 |
| N0-vs-N1 |
2.524800E-01 |
|
|
